Sep 12, 2023 / 01:05PM GMT
Catherine Walden Ramsey Schulte - Robert W. Baird & Co. Incorporated, Research Division - Senior Research Analyst
So we're going to go ahead and get started. I'm Catherine Schulte, I cover life sciences and diagnostics here at Baird. Very excited to have Azenta here with us today. Here from the company, we have the CFO, Lindon Robertson. He's going to run through a presentation. And if we have time at the end, we'll take some questions. If you want to send in a question, I think we are Session 2, so [email protected]. Thanks.
Lindon G. Robertson - Azenta, Inc. - Executive VP & CFO
Thank you, Catherine. It's very nice to be here and it looks to be a very robust day today. The halls are full. So we're looking forward to the one-on-one meetings. But here -- thank you for your attention on Azenta here at the Baird Conference.
I'll highlight the safe harbor statement. Of course, we'll be making forward-looking statements in our presentation. We'll also be using non-GAAP metrics. We always encourage you to compare those to and use those in
Azenta Inc at Robert W Baird Global Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot